Open AccessThe Risk of Developing Type 2 Diabetes Mellitus Associated With Psychotropic Drug Use in Children and Adolescents
Author(s) -
Jeanette M. Jerrell,
Avnish Tripathi,
Ali A. Rizvi,
Roger S. McIntyre
Publication year - 2012
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 50
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.11m01185
Subject(s) - medicine , type 2 diabetes mellitus , dyslipidemia , diabetes mellitus , overweight , cohort , pediatrics , depression (economics) , obesity , antipsychotic , type 2 diabetes , retrospective cohort study , psychiatry , schizophrenia (object oriented programming) , endocrinology , economics , macroeconomics
Type 2 diabetes mellitus in children and adolescents has become an important public health concern, in parallel with the "epidemic" of overweight/obesity in this age group and a sharp increase in children being prescribed antidepressant or antipsychotic medications. In children and adolescents, the prevalence of being prescribed antidepressant or antipsychotic medications was examined as well as the association of these medications with developing type 2 diabetes mellitus.